VMB-100

N/A

Report date: 2025/05/21 14:48:59

Base Information

Drug NameVMB-100
Drug Alias NameVMB-100
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInsulin-like growth factor I stimulants
TargetsInsulin-like growth factor I
Therapy Area/IndicationsUrinary Incontinence, Stress
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTouchlight Genetics LtdVersameb AG
China Registration ClassN/A

Develop Information

Active CompaniesVersameb AGTouchlight Genetics Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Incontinence, Stress
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A